Skip to main content
Journal of Cachexia, Sarcopenia and Muscle logoLink to Journal of Cachexia, Sarcopenia and Muscle
. 2026 Aug 4;17(4):e70352. doi: 10.1002/jcsm.70352

Correction to ‘A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non‐Small Cell Lung Cancer With Cachexia (SPIRAL‐ANA)’

PMCID: PMC13437656  PMID: 42552565

Morimoto K, Uchino J, Hibino M, et al., “A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non‐Small Cell Lung Cancer With Cachexia (SPIRAL‐ANA),” Journal of Cachexia, Sarcopenia and Muscle 17, no. 4 (2026): e70340, https://onlinelibrary.wiley.com/doi/10.1002/jcsm.70340.

In the published version, the second sentence of the Acknowledgements section reads:

Data management and monitoring for this study were conducted by CReS Kyushu under a funding contract with Chugai Pharmaceutical Co. Ltd.

The correct sentence should be:

Data management and monitoring for this study were conducted by CReS Kyushu under a funding contract with Ono Pharmaceutical Co. Ltd.

We apologize for this mistake.


Articles from Journal of Cachexia, Sarcopenia and Muscle are provided here courtesy of Wiley

RESOURCES